The role of mastery in Crohn's disease: a cross-sectional study

Marina Francesca Gattoni1,2, Enrica Previtali3, Salvatore Leone3

  • 1University of Florence, Florence, Italy.

Insights

Mastery is impaired in Crohn's disease (CD) patients, particularly men with mild symptoms, and linked to distress and anxiety. Further research is needed on mastery's role in medical adherence for CD management.

Area of Science:

  • Gastroenterology
  • Psychology
  • Health Sciences

Background:

  • Crohn's disease (CD) is a chronic autoimmune condition impacting quality of life (QoL).
  • Approximately 40% of CD patients exhibit non-adherence to medical prescriptions, increasing risks of hospitalization and surgery.
  • CD significantly affects mental health, with 'mastery' (ability to manage life events) being a key factor.

Purpose of the Study:

  • To investigate the relationship between mastery and medical adherence in CD patients.
  • To explore the association of mastery with distress, social support, QoL, and psychological symptoms.
  • To examine the role of interoception in the context of mastery and CD.

Main Methods:

  • A cross-sectional study involving 261 adults diagnosed with CD.
  • Online questionnaires utilized validated clinical and psychological scales.
  • Data collection included medical reports for context.

Main Results:

  • CD patients reported varying levels of mastery, with significant differences based on clinical conditions and a gender-symptomatology interaction.
  • Mastery showed a significant association with clinical conditions, QoL, stress, and interoception (adjusted R² = 0.558).
  • No significant mediating role of mastery was found between psychological state and medical adherence.

Conclusions:

  • Mastery is notably impaired in CD patients, especially men with mild disease.
  • A positive link exists between mastery and interoception, alongside higher distress, anxiety, and depressive symptoms.
  • Future research should further explore the connection between mastery and medical adherence in CD.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...